Diabetes, Metabolic Syndrome and Obesity (Jul 2024)

Factors Influencing Therapeutic Non-Adherence Behavior Among Patients with Type 2 Diabetes in Two Public Hospitals in the Gambia: A Cross-Sectional Study

  • Omotosho TOA,
  • Senghore T

Journal volume & issue
Vol. Volume 17
pp. 2683 – 2692

Abstract

Read online

Tobiloba Oyejide Alex Omotosho,1,2 Thomas Senghore1 1Department of Nursing and Reproductive Health, The University of the Gambia, Banjul, Gambia; 2Department of Surgery, Edward Francis Small Teaching Hospital, Banjul, GambiaCorrespondence: Tobiloba Oyejide Alex Omotosho, Department of Nursing and Reproductive Health, The University of the Gambia, Banjul, Gambia, Tel +220 3060114, Email [email protected]: Type 2 Diabetes Mellitus (DM) is a significant public health problem in The Gambia. While therapeutic non-adherence is widely recognized as a common and costly problem, very little is known about therapeutic adherence behavior among patients with diabetes in The Gambia.Purpose: The objective of this study was to determine the prevalence and factors that influence diabetic therapeutic non-adherence behavior among patients with type 2 diabetes in The Gambia.Methods: A cross-sectional study design was used, and participants were recruited from Edward Francis Small Teaching Hospital (EFSTH) and Kanifing General Hospital (KGH). The sample size of 145 patients with type 2 diabetes was included and data was collected using a structured questionnaire. Adherence to anti-diabetic medications was measured using the Morisky Medications Adherence Scale (MMAS-8). Logistic regression was used to determine the factors associated with diabetic therapeutic non-adherence.Results: The prevalence of non-adherence to anti-diabetic treatment was 27.6%. Perceived barrier (forgetfulness, long-term medication use, and medication side effects) to diabetic treatment (OR = 0.265, 95% CI: 0.113– 0.621, p = 0.041) was statistically significantly associated with non-adherence to anti-diabetic treatment. However, the frequency of doctor’s visits (OR = 0.310, 95% CI: 0.046– 2.111) was not significantly associated with non-adherence to anti-diabetic treatment.Conclusion: The rate of non-adherence to antidiabetic treatment in this study was high. Perceived barriers to antidiabetic treatment such as forgetfulness, long-term medication use, and medication side effects influenced therapeutic non-adherence to antidiabetic treatment. While interventions should focus on how to eliminate these barriers, health education on diabetic self-care may help reinforce the importance of medication adherence to prevent complications.Keywords: Type 2 diabetes, Health Education, Barriers, EFSTH, KGH, The Gambia

Keywords